Analyst Recommendations

Citigroup analyst issues BUY recommendation for AMAT on February 4, 2026 11:16AM ET. The previous analyst recommendation was Buy.AMAT was trading at $318.67 at issue of the analyst...

February 4, 2026   AMAT 1.36%

Citigroup analyst issues BUY recommendation for TDC on February 4, 2026 11:18AM ET. The previous analyst recommendation was Buy.TDC was trading at $26.03 at issue of the analyst...

February 4, 2026   TDC 0.08%

Wells Fargo analyst issues OVERWEIGHT recommendation for WTW on February 4, 2026 11:22AM ET. The previous analyst recommendation was Overweight.WTW was trading at $335.1 at issue of the...

February 4, 2026   WTW 0.64%

Wells Fargo analyst issues OVERWEIGHT recommendation for BALL on February 4, 2026 11:26AM ET. The previous analyst recommendation was Overweight.BALL was trading at $61.77 at issue of the...

February 4, 2026   BALL -0.02%

Citigroup analyst issues NEUTRAL recommendation for AMGN on February 4, 2026 11:20AM ET. The previous analyst recommendation was Neutral.AMGN was trading at $338.59 at issue of the analyst...

February 4, 2026   AMGN 0.01%

Wells Fargo analyst issues OVERWEIGHT recommendation for TTWO on February 4, 2026 11:25AM ET. The previous analyst recommendation was Overweight.TTWO was trading at $212.17 at issue of the...

February 4, 2026   TTWO -0.46%

UBS analyst issues NEUTRAL recommendation for MDLZ on February 4, 2026 11:31AM ET. The previous analyst recommendation was Neutral.MDLZ was trading at $59.47 at issue of the analyst...

February 4, 2026   MDLZ 4.12%

Wells Fargo analyst issues OVERWEIGHT recommendation for HUBB on February 4, 2026 11:28AM ET. The previous analyst recommendation was Overweight.HUBB was trading at $503.86 at issue of the...

February 4, 2026   HUBB 1.19%

UBS analyst issues BUY recommendation for FDX on February 4, 2026 11:29AM ET. The previous analyst recommendation was Buy.FDX was trading at $353.43 at issue of the analyst...

February 4, 2026   FDX 0.32%

Wells Fargo analyst issues POSITIVE recommendation for EMR on February 4, 2026 11:31AM ET. The previous analyst recommendation was Positive.EMR was trading at $152.1 at issue of the...

February 4, 2026   EMR 0.79%